BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 2
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study
©The Author(s) 2026.
World J Clin Oncol. Feb 24, 2026; 17(2): 116251
Published online Feb 24, 2026. doi: 10.5306/wjco.v17.i2.116251
Table 4 Multivariable Cox model for disease-free survival
Variable
Adjusted HR (95%CI)
P value
CSC positive0.86 (0.43-1.73)0.675
Age (per year)1.01 (0.99-1.03)0.274
Grade (per level)1.31 (0.98-1.74)0.068
Stage II (vs I)0.92 (0.57-1.48)0.721
Stage III (vs I)0.80 (0.50-1.30)0.369
CSC: Cancer stem cell; HR: Hazard ratio; CI: Confidence interval.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.